Growth Equity

NewAlpha Verto is a Growth Equity fund which supports profitable and fast-growing SMEs.

Investment in equity, as a majority or a strategic minority shareholder, through cash-in and / or cash-out situations


    3 sectors benefiting from demonstrated growth potential: Technology, Healthcare, Industrial niches / Greentech

    A dedicated investment team, advised by an Orias-approved CIF structure and supported by an operational committee of sector experts.


    Supporting the operational growth of SMEs: organic development, recruitment of key people, etc.

    Supporting the management team to implement its external growth strategy


    Demonstrated know-how to develop SMEs outside of their domestic markets, through organic expansion or strategic acquisitions

NewAlpha Verto is specialized in Growth Equity investments, and supports the transformation of ambitious SMEs into mid-cap companies.

We support profitable, technology-based companies with significant growth potential.

NewAlpha Verto invests equity tickets between €7m and €30m. We support ambitious and motivated management teams, who invest significantly alongside NewAlpha Verto.

We invest in SMEs headquartered in France, Benelux or Switzerland, with a presence or ambition that extends beyond domestic borders.

The investment team comprises 5 dedicated professionals, including 4 partners combining more than 40 years of experience in private equity.

They also benefit from the experience and network of an operational committee made up of 10 managers or former managers of SMEs or large companies, who are opinion leaders in the fund's areas of specialization.

NewAlpha is committed to sustainable investment, and actively and systematically supports its portfolio companies through their ESG transition.

Investment criteria

  • SMEs operating in
    Technology, Healthcare,
    or Industrial Niches (including GreenTech)

  • SMEs headquartered
    in France, Benelux or Switzerland,
    with an international presence or potential

  • Profitable companies,
    with strong organic growth,
    and significant development potential

  • Equity tickets
    between €7m and €30m

  • Position as a reference shareholder,
    majority or minority,
    alongside the management teams

  • Capital increase
    or shareholder reconfiguration,
    with or without financial leverage

The team